阿片类药物治疗方案中的丙型肝炎病毒治疗远程医疗

IF 45.9 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Nature Reviews Gastroenterology &Hepatology Pub Date : 2024-05-15 DOI:10.1038/s41575-024-00942-z

Jordan Hindson

引用次数: 0

摘要

一项前瞻性随机临床试验（NCT02933970）比较了通过纳入阿片类药物治疗计划的远程医疗（n = 290）与标准护理非现场肝炎专家转诊（n = 312）治疗丙型肝炎病毒感染的疗效。该研究在美国纽约的阿片类药物治疗项目中进行。在远程医疗组中，92.4%的患者开始接受治疗，而在转诊组中，只有40.4%的患者开始接受治疗。远程医疗组的意向治疗治愈率为 90.3%，转诊组为 39.4%。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Telemedicine for hepatitis C virus treatment in opioid treatment programmes

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Reviews Gastroenterology &Hepatology 医学-胃肠肝病学

CiteScore

52.30

自引率

0.60%

发文量

147

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Gastroenterology & Hepatology aims to serve as the leading resource for Reviews and commentaries within the scientific and medical communities it caters to. The journal strives to maintain authority, accessibility, and clarity in its published articles, which are complemented by easily understandable figures, tables, and other display items. Dedicated to providing exceptional service to authors, referees, and readers, the editorial team works diligently to maximize the usefulness and impact of each publication. The journal encompasses a wide range of content types, including Research Highlights, News & Views, Comments, Reviews, Perspectives, and Consensus Statements, all pertinent to gastroenterologists and hepatologists. With its broad scope, Nature Reviews Gastroenterology & Hepatology ensures that its articles reach a diverse audience, aiming for the widest possible dissemination of valuable information. Nature Reviews Gastroenterology & Hepatology is part of the Nature Reviews portfolio of journals.